Elkony M, Elsisi G. Cost Minimization Analysis of Secukinumab versus Infliximab in Egyptian Patients with Ankylosing Spondylitis from Health Care Provider Perspective. Poster presentation PMS59 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain. Assal R, Elsisi G. Cost Effectiveness Analysis of Pegylated Liposomal and Nonliposomal Doxorubicin Formulations for the First Line Treatment of Metastatic Breast...